Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
147.18
-0.87 (-0.59%)
At close: Nov 11, 2026, 4:00 PM EST
147.41
+0.23 (0.16%)
After-hours: Nov 11, 2026, 7:59 PM EST

Merck & Co. Revenue

Merck & Co. had revenue of $18.09B in the quarter ending September 30, 2026, with 4.68% growth. This brings the company's total for the last twelve months to $67.38B, up 4.89% year-over-year. In the year 2025, Merck & Co. had annual revenue of $65.01B with 1.31% growth. That makes Merck & Co. the 180th largest company in the world by revenue and 72nd in the United States.

Revenue (ttm)
$67.38B
Revenue Growth
+4.89%
P/S Ratio
5.39
Revenue / Employee
$898,373
Employees
75,000
Market Cap
362.83B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Keytruda/Keytruda Qlex 31.68B 48.7%
  • Animal Health 6.35B 9.8%
  • Gardasil/Gardasil 9 5.23B 8.0%
  • Januvia/Janumet 2.54B 3.9%
  • ProQuad/M-M-R II/Varivax 2.45B 3.8%
  • Bridion 1.84B 2.8%
  • Lynparza - Alliance 1.45B 2.2%
  • Other 13.46B 20.7%

By Geography

Chart
  • United States 36.51B 56.2%
  • Europe, Middle East and Africa 14.58B 22.4%
  • Latin America 3.41B 5.2%
  • Asia Pacific (other than China and Japan) 2.98B 4.6%
  • Other Geographic 2.88B 4.4%
  • Japan 2.71B 4.2%
  • China 1.94B 3.0%
Fiscal year ended Dec 31, 2025 See the full Merck & Co. breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.01B843.00M1.31%
Dec 31, 202464.17B4.05B6.74%
Dec 31, 202360.12B832.00M1.40%
Dec 31, 202259.28B10.58B21.72%
Dec 31, 202148.70B7.19B17.31%
Dec 31, 202041.52B-5.32B-11.36%
Dec 31, 201946.84B4.55B10.75%
Dec 31, 201842.29B2.17B5.41%
Dec 31, 201740.12B315.00M0.79%
Dec 31, 201639.81B309.00M0.78%
Dec 31, 201539.50B-2.74B-6.48%
Dec 31, 201442.24B-1.80B-4.08%
Dec 31, 201344.03B-3.23B-6.84%
Dec 31, 201247.27B-780.00M-1.62%
Dec 31, 201148.05B2.06B4.48%
Dec 31, 201045.99B18.56B67.66%
Dec 31, 200927.43B3.58B15.00%
Dec 31, 200823.85B-347.70M-1.44%
Dec 31, 200724.20B13.60B128.41%
Dec 31, 200610.59B1.09B11.42%
Dec 31, 20059.51B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson99.34B
Eli Lilly and Company86.46B
AbbVie66.01B
Pfizer63.62B
AstraZeneca62.38B
Sanofi57.89B
Novartis AG57.36B
Novo Nordisk50.70B
Revenue Rankings